MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 99 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,195 | -32.1% | 8,000 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $1,761 | +30.5% | 8,000 | +37.9% | 0.00% | +33.3% |
| Q1 2023 | $1,349 | -21.0% | 5,800 | 0.0% | 0.00% | -40.0% |
| Q4 2022 | $1,708 | -99.9% | 5,800 | -77.5% | 0.01% | -28.6% |
| Q2 2021 | $2,489,000 | +58.2% | 25,750 | +87.3% | 0.01% | +40.0% |
| Q1 2021 | $1,573,000 | +205.4% | 13,750 | +189.5% | 0.01% | +150.0% |
| Q4 2020 | $515,000 | -63.1% | 4,750 | -18.8% | 0.00% | -75.0% |
| Q1 2019 | $1,395,000 | 0.0% | 5,850 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $1,395,000 | -16.4% | 5,850 | -2.5% | 0.01% | -27.3% |
| Q2 2018 | $1,668,000 | – | 6,000 | +299900.0% | 0.01% | – |
| Q4 2017 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 2 | -50.0% | 0.00% | – |
| Q3 2016 | $0 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 1,402,250 | $93,614,000 | 4.00% |
| Parkman Healthcare Partners LLC | 30,000 | $2,003,000 | 0.93% |
| ARMISTICE CAPITAL, LLC | 216,000 | $14,420,000 | 0.89% |
| Avoro Capital Advisors LLC | 349,000 | $23,299,000 | 0.79% |
| Rock Springs Capital Management LP | 250,000 | $16,690,000 | 0.69% |
| Capital Impact Advisors, LLC | 24,351 | $1,626,000 | 0.68% |
| Baker Brothers Advisors | 1,499,212 | $100,087,000 | 0.62% |
| EWG Elevate Inc. | 11,086 | $740,000 | 0.56% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $801,000 | 0.54% |
| DAFNA Capital Management LLC | 13,600 | $908,000 | 0.38% |